# Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/preclinical-selection-of-a-novel-poly-adp-ribose-polymerase-inhibitor-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Huw D. Thomas,Christopher Calabrese,Michael A. Batey,Stacie Canan,Zdeněk Hostomský,Suzanne Kyle,Karen A. Maegley,David R. Newell,Donald J. Skalitzky,Lan-Zhen Wang,Stephen E. Webber,Nicola J. Curtin |
| Citations | 304 |
| DOI | 10.1158/1535-7163.mct-06-0552 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2165091409 |
| PMID | 17363489 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Christopher Calabrese](https://scholariq.org/researchers/christopher-calabrese/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [DNA Repair Mechanisms](https://scholariq.org/topics/dna-repair-mechanisms/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.